All News
A Convergence of Ideas: COVID19 and ACR
Since the beginning of the pandemic, rheumatologists scrambled to figure out how the SARS-CoV-2 virus will affect their patients with immune mediated inflammatory diseases (IMID). Meeting the needs of patients, managing a practice, and trying to balance a home life have many doctors stressed.
Read ArticleSpondyloarthritis at ACR Convergence 2020
There are some really interesting poster and abstract presentations on spondyloarthritis at the ACR Convergence 2020. I’ll be covering these topics, and discussing select individual posters and abstracts during this meeting.
Read ArticleInfection and Rheumatic Diseases: A New Dawn
Infection in the setting of autoimmune rheumatic disease (ARD) has been the subject of increasing research and clinical interest for decades. Despite the huge burden of infection in patients with ARDs, this area of research has really been catapulted to the centre-stage of research agendas and coverage at congresses, including ACR 2020, with the arrival of the coronavirus disease 2019 (COVID-19) pandemic.
Read ArticleQD Clinic Podcast - 106 thru 109
Here is the last of our QD Clinics in Podcast form, just before we start ACR2020 coverage.
In this compilation from the past week we talk about
- HIV and arthritis
- Hyperuricemia in PsA
- An odd kind of dermatomyositis
Read ArticleEric Dein ejdein1 ( View Tweet)
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
Jeff Sparks jeffsparks ( View Tweet)
Richard Conway RichardPAConway ( View Tweet)
Peter Nash drpnash ( View Tweet)
Peter Nash drpnash ( View Tweet)
Peter Nash drpnash ( View Tweet)
Peter Nash drpnash ( View Tweet)
American College of Rheumatology ACRheum ( View Tweet)
ATS Clinical Problems Assembly ATSCPAssembly ( View Tweet)
Peter Nash drpnash ( View Tweet)
Links: